Notably, the population of IL17‐producing γδT cell, rather than Th17 cell, was significantly decreased in IMQ_986165 group (Figure 2E), implying that the modulation of psoriasis outcomes by topical TYK2 inhibitor was not relied on suppressing Th17 cell function. The gene discussed is TYK2; the disease is psoriasis.